This decades-long existing class of meds GLP-1 receptor agonists, had helped people with diabetes lose weight but could also help people without diabetes but with chronic conditions like PCOS or insulin resistance, lose weight
drug safety standards.Only firms on this list will be permitted to import GLP-1 active pharmaceutical ingredients (APIs) into the United States.[1] The import alert empowers FDA field personnel to detain, without physical examination, shipments of GLP-1 APIs from unapproved foreign sources not included on the Green List. This initiative appears to be part of a broader strategy to prevent the distribution of unsafe or misbranded GLP-1 products, which FDA states have been linked to dosing errors, contamination, and adverse health outcomes
More compounds mean more options, more data, and ultimately better outcomes
Jamieson, D
Theyre putting the right systems of support in place early and recognizing where GLP1 care is headed, not just where it is today
Choose a treatment plan and pay
